all videos
High residual cardiovascular risk, the action of purified icosapent ethyl
it
Prof. Gaetano De Ferrari
"Colesterolo di confine": perchè è un pericolo, come controllarlo
it
Prof. Claudio Ferri
LDL Targets in High-Risk Patients, What Therapeutic and Communication Strategies?
it
Prof. Daniele Andreini
Oxidized LDL and Atherosclerosis: waiting for the vaccine
en
Prof. Jawahar Mehta
Insights from REDUCE-IT: understanding the clinical benefit of icosapent ethyl
en
Dr. Hussain Contractor
Treatment of hypercholesterolemia in patients at high cardiovascular risk
it
Dr. Claudio D’Angelo
Hypercholesterolemia: comparison of available combination strategies
it
Prof. Maria Lorenza Muiesan
Personalising diet in individuals with pre-diabetes: how to mitigate the risk to develop T2DM
en
Prof. Pedro Marques-Vidal
Clinical efficacy and safety of achieving very low LDL levels
it
Robert Giugliano, MD
JET-LDL Registry Northern Italy, results on ACS patients after PCI
it
Dr. Giuseppe Musumeci
LDL, nuovi valori limite per ridurre le cardiopatie ischemiche
it
Dr. Michele Gulizia
Study reveals: LDL lowering depends on how it is lowered
en
Prof. Brian A Ference